- Home
- KYMR vs WK Comparison
KYMR vs WK Comparison
Compare KYMR & WK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- WK
- Stock Information
- Founded
- KYMR 2015
- WK 2008
- Country
- KYMR United States
- WK United States
- Employees
- KYMR N/A
- WK N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- WK Computer Software: Prepackaged Software
- Sector
- KYMR Health Care
- WK Technology
- Exchange
- KYMR Nasdaq
- WK Nasdaq
- Market Cap
- KYMR 3.1B
- WK 3.7B
- IPO Year
- KYMR 2020
- WK 2014
- Fundamental
- Price
- KYMR $43.51
- WK $79.89
- Analyst Decision
- KYMR Strong Buy
- WK Strong Buy
- Analyst Count
- KYMR 15
- WK 9
- Target Price
- KYMR $58.53
- WK $102.56
- AVG Volume (30 Days)
- KYMR 722.6K
- WK 773.0K
- Earning Date
- KYMR 10-30-2025
- WK 11-05-2025
- Dividend Yield
- KYMR N/A
- WK N/A
- EPS Growth
- KYMR N/A
- WK N/A
- EPS
- KYMR N/A
- WK N/A
- Revenue
- KYMR $44,711,000.00
- WK $806,977,000.00
- Revenue This Year
- KYMR $58.45
- WK $21.48
- Revenue Next Year
- KYMR N/A
- WK $15.68
- P/E Ratio
- KYMR N/A
- WK N/A
- Revenue Growth
- KYMR N/A
- WK 19.02
- 52 Week Low
- KYMR $19.45
- WK $60.50
- 52 Week High
- KYMR $53.27
- WK $116.83
- Technical
- Relative Strength Index (RSI)
- KYMR 53.28
- WK 57.26
- Support Level
- KYMR $39.84
- WK $75.90
- Resistance Level
- KYMR $43.43
- WK $82.66
- Average True Range (ATR)
- KYMR 2.03
- WK 2.25
- MACD
- KYMR 0.15
- WK -0.26
- Stochastic Oscillator
- KYMR 78.76
- WK 67.27
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About WK Workiva Inc.
Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.